rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1986-1-22
|
pubmed:abstractText |
During a period of 3 years we observed 5 patients with chronic active hepatitis B and 2 with hepatitis B virus-induced liver cirrhosis who cleared HBsAg from their sera after 2-14 years of HBsAg carriership. 4 of them developed anti-HBs. After HBsAg clearance there was no evidence of persisting inflammatory activity within their livers. 5 of the 7 patients had been treated for 1-39 months with prednisolone, sometimes in combination with azathioprine. This therapy, however, had been stopped more than 3 years before these patients terminated their HBsAg carriership. Our observations indicate that even after long-standing chronic active hepatitis B or hepatitis B virus-induced liver cirrhosis HBsAg may be eliminated in a considerable number of patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0012-2823
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-60
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3940237-Adult,
pubmed-meshheading:3940237-Alanine Transaminase,
pubmed-meshheading:3940237-Aspartate Aminotransferases,
pubmed-meshheading:3940237-Carrier State,
pubmed-meshheading:3940237-Female,
pubmed-meshheading:3940237-Hepatitis, Chronic,
pubmed-meshheading:3940237-Hepatitis B,
pubmed-meshheading:3940237-Hepatitis B Antibodies,
pubmed-meshheading:3940237-Hepatitis B Surface Antigens,
pubmed-meshheading:3940237-Humans,
pubmed-meshheading:3940237-Liver Cirrhosis,
pubmed-meshheading:3940237-Male,
pubmed-meshheading:3940237-Middle Aged,
pubmed-meshheading:3940237-Time Factors
|
pubmed:year |
1986
|
pubmed:articleTitle |
HBsAg clearance in patients with long-standing chronic active hepatitis B and hepatitis B virus-induced liver cirrhosis.
|
pubmed:publicationType |
Journal Article,
Case Reports
|